Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine ER in Patients With Overactive Bladder. - Related Studies

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine ER in Patients With Overactive Bladder.

This study is currently recruiting participants.

Study NCT00611026. Last updated on October 8, 2008. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Overactive Bladder

2	Additional conditions recognized in this trial
		Urinary Bladder, Overactive

3	More general conditions related to this trial
		Signs and Symptoms
		Urinary Bladder Diseases
		Urologic Diseases
		Urological Manifestations

4	Interventions listed in this trial
		Tolterodine ER
		Placebo
		Fesoterodine

5	Additional drug interventions recognized in this trial
		Tolterodine

6	More general drug interventions related to this trial
		Cholinergic Agents
		Cholinergic Antagonists
		Molecular Mechanisms of Pharmacological Action
		Muscarinic Antagonists
		Neurotransmitter Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Pfizer